Dr. Olga Kubassova

Dr. Olga Kubassova Email and Phone Number

President and CEO @ IMAGE ANALYSIS GROUP
United Kingdom
Dr. Olga Kubassova's Location
United Kingdom, United Kingdom
Dr. Olga Kubassova's Contact Details

Dr. Olga Kubassova work email

Dr. Olga Kubassova personal email

n/a
About Dr. Olga Kubassova

Mathematician with 10+ years expertise in actively managing innovation in life science companies, asset positioning, strategy and capital raising. Extensive expertise and domain knowledge in identifying innovative approaches to clinical research, disruptive technology platforms and novel therapeutics. Olga is a renowned healthcare innovator and biotech investor, with passion for improving people’s health. Olga is an active researcher, co-author of 120+ publications, books and book chapters.She is a scientific adviser and venture partner to several investment funds, biotechnology and pharma companies, to the UK government and EU funding bodies. She is a founding member of 'The 2% club' to support women in leadership positions, scholar of the Royal Society of Medicine, Royal Academy of Engineering, alumni of several business leadership programs by Goldman Sachs, Oxford Said Business School, Business School of University of Leeds, alumni of Business Programme by the New York Economic Development (New York Venture Fellows), 4 time winner of the national and international 'Entrepreneur of the Year' award.

Dr. Olga Kubassova's Current Company Details
IMAGE ANALYSIS GROUP

Image Analysis Group

View
President and CEO
United Kingdom
Website:
ia-grp.com
Employees:
47
Dr. Olga Kubassova Work Experience Details
  • Image Analysis Group
    President And Ceo
    Image Analysis Group
    United Kingdom
  • Iag, Image Analysis Group
    President | Founder
    Iag, Image Analysis Group Feb 2024 - Present
    London, Gb
    Leading imaging Clinical Research Organization (iCRO) that combines medical expertise, world-class operational team with with the best-in-class proprietary platform DYNAMIKA for data management, central review and deployment of Artificial Intellegence (AI) at scale. IAG has been serving biotech and pharma clients globally for nearly 20 years, helping to use medical imaging and image-driven endpoints to assess safety and efficacy of novel drug candidates across multiple indications. With a pioneering proven innovation strategy, we enhance the value and market potential of novel therapeutic assets and reduce the risks of R&D, as demonstrated through successful pharmaceutical partnerships. www.ia-grp.comReach out: imaging.experts@ia-grp.com
  • Iag, Image Analysis Group
    Chief Executive Officer
    Iag, Image Analysis Group Jul 2007 - Jan 2024
    London, Gb
    Getting drugs approved and assets partnered through robust data delivered via IAG's proprietary technology platform DYNAMIKA, global operations, expertise in radiology and Artificial Intelligence. www.ia-grp.com
  • Bio Capital Impact Fund - Investing In What Matters
    Investment Professional | Venture Partner
    Bio Capital Impact Fund - Investing In What Matters Mar 2019 - Present
    Melbourne, Victoria, Au
    Bio Capital Impact Fund - a new ever-green investment fund, set-up to make a difference in the world of biotechnology, medical device and healthcare. The fund brings together a team of investment professionals with global experience and track record in commercialisation, licencing, fund development and investment management across Asia, Europe and North America. The Fund invests in innovative and disruptive technologies in the biotech space and high growth diversified international later stage investments. We make investments that matter to people because they make lives better or improve society as a whole. We are looking to build alliances and collaborations with strategic partners, such as pharmaceutical companies, research institutes and universities.
  • Indaco Venture Partners
    Advisor
    Indaco Venture Partners Jan 2024 - Present
    Milano, Lombardia, It
    Indaco Venture Partners SGR is the largest independent Italian venture capital asset management company, with a strong specialization in companies that innovate in electronics and robotics, medtech, digital and new materials.Indaco manages over 250 million across its five funds. Investments in Indaco Ventures Fund I are focused on growth-stage companies whose competitive advantage stems from cutting-edge proprietary technologies and innovations. In terms of teams and technologies, the focus is on Italian enterprises, although investments are made throughout Europe, USA, Canada and Israel.
  • Mimedx
    Scientific Advisory Board Member
    Mimedx Jun 2022 - Present
    Marietta, Georgia, Us
  • Werfen
    Scientific Advisory Board Member
    Werfen Jun 2019 - Present
    L'Hospitalet De Llobregat, Barcelona, Es
  • Curematch, Inc.
    Advisory Board Member
    Curematch, Inc. May 2018 - Present
    San Diego, Ca, Us
  • Analytics Ventures
    Venture Partner
    Analytics Ventures Jan 2018 - Present
    San Diego, California, Us
    Investments into companies focused on using Artificial Intelligence and Machine Learning. Analytics Ventures was founded to fund and help building some of the most innovative data businesses of our generation. We are believers that mankind is on the verge of the most rapid transformation ever due to the growing symbiotic relationship between human and artificial intelligence. As such, we have developed a front-to-end venture studio that provides a proven execution framework to drive the highest probability of success and rapid market validation.Portfolio Companies: dynam.ai, Zerise, CureMetrix, AdTheos, CureMatch, tinoro, kazuhm, alphatrAI https://www.analytics-ventures.com/
  • Professional Journals
    Member Of The Editorial Board
    Professional Journals Jan 2013 - Present
    Arthritis & Rheumatology, ACRArthritis & Rheumatology is a monthly peer-reviewed medical journal covering the natural history, pathophysiology, treatment, and outcome of the rheumatic diseases. It is an official journal of the American College of RheumatologyRheumatology, Oxford University Press Rheumatology is an international peer reviewed academic journal publishing the highest quality scientific (basic and translational) and clinical-epidemiological papers on a wide range of paediatric and adult rheumatological and musculoskeletal conditions, including topics such as therapy, surgery, imaging and education.Journal of Magnetic Resonance Imagingis the first international multidisciplinary journal encompassing physical, life, and clinical science investigations as they relate to the development and use of magnetic resonance imaging. MRI is dedicated to both basic research and medical applications, providing a single forum for communication among radiologists, physicists, chemists, biochemists, biologists, engineers, internists, pathologists, physiologists, computer scientists, and mathematicians.The Journal of Aging & Age Related Diseasesis a peer-reviewed journal that aims to publish the latest research in the field of aging and diagnosis, prevention, treatment of age-related diseases. The journal publishes original research articles, review articles, clinical reports, case studies, commentaries, editorials, and letters to the Editor. http://www.jscimedcentral.com/Aging/aims-scope.phpJournal of Immunology Research, Journal of Immunology Research is a peer-reviewed, Open Access journal that publishes research articles, review articles, as well as clinical studies in all aspects of immunology research.Impact Factor for Journal of Immunology Research is 2.812 http://www.hindawi.com/journals/jir/
  • Lcmh Advisory Board
    Board Member
    Lcmh Advisory Board Jan 2013 - Present
    The University of Liverpool has established a new £60M Centre for Mathematical Sciences in Healthcare (LCMH) to develop novel mathematical tools that address serious healthcare challenges. The new Centre is carrying out multidisciplinary research to explore how mathematics and statistics can deliver a more refined and accurate set of predictive models and tools for personalised healthcare delivery. LCMH brings together industrial partners and policy makes, 15 UK universities and 40 NHS trusts.
  • European Commission
    Expert, European Commission
    European Commission Jan 2013 - Present
    Brussels, Be
    The European Commission (EC) is an institution of the European Union, responsible for proposing legislation, implementing decisions, upholding the EU treaties and managing the day-to-day business of the EU.The EU Health Programme is the main instrument that the Commission uses to implement the EU Health Strategy. Annual work plans of the Programme set out priority areas and the criteria for its funding actions. The total budget for the programme is € 449.4 million.https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/3hp/index.html#c,calls=hasForthcomingTopics/t/true/1/1/0/default-group&hasOpenTopics/t/true/1/1/0/default-group&allClosedTopics/t/true/0/1/0/default-group&+PublicationDateLong/asc

Dr. Olga Kubassova Skills

Medical Imaging Strategy Clinical Trials Clinical Research Management Oncology Entrepreneurship Image Analysis Medical Devices R&d Biotechnology Healthcare Data Analysis Life Sciences Pharmaceutical Industry Venture Capital Cancer Research And Development Enterprise Software Radiology Commercialization Lifesciences Product Launch Company Management Fundraising Innovation Management Science Immunology Clinical Study Design Statistical Modeling Biotechnology Industry Healthcare Information Technology Consulting

Dr. Olga Kubassova Education Details

  • University Of Leeds
    University Of Leeds
    Computer Science
  • Saïd Business School, University Of Oxford
    Saïd Business School, University Of Oxford
    Master Of Business Administration - Mba
  • Institute Of Directors (Iod)
    Institute Of Directors (Iod)
  • Lut University
    Lut University
    Information Technology
  • Saint Petersburg State University
    Saint Petersburg State University
    Department Of Mathematics And Mechanics

Frequently Asked Questions about Dr. Olga Kubassova

What company does Dr. Olga Kubassova work for?

Dr. Olga Kubassova works for Image Analysis Group

What is Dr. Olga Kubassova's role at the current company?

Dr. Olga Kubassova's current role is President and CEO.

What is Dr. Olga Kubassova's email address?

Dr. Olga Kubassova's email address is ol****@****grp.com

What schools did Dr. Olga Kubassova attend?

Dr. Olga Kubassova attended University Of Leeds, Saïd Business School, University Of Oxford, Institute Of Directors (Iod), Lut University, Saint Petersburg State University.

What are some of Dr. Olga Kubassova's interests?

Dr. Olga Kubassova has interest in Compound Positioning, Investment Strategy, Medical Image Analysis, Algorithms, Regulatory Strategy In Usa And Eu, Clinical Trial Design, Pharma And Biotech Market.

What skills is Dr. Olga Kubassova known for?

Dr. Olga Kubassova has skills like Medical Imaging, Strategy, Clinical Trials, Clinical Research, Management, Oncology, Entrepreneurship, Image Analysis, Medical Devices, R&d, Biotechnology, Healthcare.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.